Bank Of America Corp Monopar Therapeutics Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $0.94 $35 - $57	61 Added 12.2%	561 $0
Q1 2024 May 15, 2024	BUY	$0.31 - $1.35 $155 - $675	500 New	500 $0
Q4 2022 Feb 10, 2023	BUY	$2.05 - $14.95 $20 - $149	10 New	10 $0
Q1 2022 May 16, 2022	SELL	$2.5 - $3.62 $17 - $25	-7 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$3.17 - $5.24 $22 - $36	7 New	7 $0

Ticker MNPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,725,800
Market Cap $316M
Description
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.